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Air pollution exposure is associated with cardiovascular mor-
bidity and mortality, yet the role of individual pollutants remains 
unclear. In particular, there is uncertainty regarding the acute 
effect of ozone exposure on cardiovascular disease. In these stud-
ies, we aimed to determine the effect of ozone exposure on vascular 
function, fibrinolysis, and the autonomic regulation of the heart. 
Thirty-six healthy men were exposed to ozone (300 ppb) and fil-
tered air for 75 min on two occasions in randomized double-blind 
crossover studies. Bilateral forearm blood flow (FBF) was meas-
ured using forearm venous occlusion plethysmography before and 
during intra-arterial infusions of vasodilators 2–4 and 6–8 h after 
each exposure. Heart rhythm and heart rate variability (HRV) 
were monitored during and 24 h after exposure. Compared with 
filtered air, ozone exposure did not alter heart rate, blood pres-
sure, or resting FBF at either 2 or 6 h. There was a dose-dependent 
increase in FBF with all vasodilators that was similar after both 
exposures at 2–4 h. Ozone exposure did not impair vasomotor or 
fibrinolytic function at 6–8 h but rather increased vasodilatation to 
acetylcholine (p = .015) and sodium nitroprusside (p = .005). Ozone 
did not affect measures of HRV during or after the exposure. Our 
findings do not support a direct rapid effect of ozone on vascular 
function or cardiac autonomic control although we cannot exclude 
an effect of chronic exposure or an interaction between ozone and 
alternative air pollutants that may be responsible for the adverse 
cardiovascular health effects attributed to ozone.
Key Words: air pollution; blood flow; endothelium; fibrinolysis; 
oxidative stress; ozone.
Exposure to air pollution is strongly associated with respira-
tory and cardiovascular morbidity and mortality. These associa-
tions are well established for exposure to fine particulate matter 
(PM) air pollution primarily from the combustion of fossil fuels 
(Brunekreef and Holgate, 2002; Miller et al., 2007).
Ozone (O
3
) is a strongly oxidative secondary air pollutant, 
and epidemiological studies have shown that ozone levels 
also correlate with respiratory and cardiovascular morbidity 
and mortality (Bell et  al., 2004, 2007; Brook et  al., 2010; 
Ito et al., 2005; Peters et al., 2004). The effects of ozone on 
health have been difficult to disentangle from the effects of PM 
in observational studies as these pollutants are often highly 
correlated. The difficulty in resolving the independent effects of 
ozone on cardiovascular mortality is illustrated by the divergent 
results published from the American Cancer Society Cancer 
Prevention Study cohort (Jerrett et al., 2009; Smith et al., 2009). 
Although Smith et al. (2009) report an independent association 
between ozone and cardiovascular death, Jerrett et al. (2009) 
found that ozone was associated only with respiratory mortality 
after adjustment for PM
2.5
. These discordant findings are not 
necessarily contradictory but may reflect differences in the 
analyses performed. Although a number of reports suggest an 
independent effect of ozone on mortality (de Almeida et  al., 
2011; Gryparis et al., 2004; Halonen et al., 2010; Ren et al., 
2008; Stafoggia et  al., 2010), acute myocardial infarction 
(Halonen et al., 2010; Ruidavets et al., 2005), and cardiac arrest 
(Ensor et  al., 2013), it remains unclear how ozone exposure 
may trigger acute nonfatal and fatal cardiovascular events.
Human chamber studies have defined the effects of short-
term exposure to ozone on the respiratory tract indicating an 
airway inflammatory response along with an alteration in anti-
oxidant defences (Behndig et al., 2009; Blomberg et al., 1999; 
Frampton et al., 1999; Stenfors et al., 2002). The evidence for a 
direct cardiovascular effect of ozone, however, is more limited. 
Exposure to ozone in combination with concentrated ambient 
particles increases peripheral arterial tone and blood pressure 
(Brook et  al., 2002; Urch et  al., 2005) although subsequent 
studies demonstrate that this may be an effect of ambient par-
ticles rather than ozone (Brook et al., 2009), and indeed ozone 
has been shown to reduce blood pressure in a diabetic popu-
lation at the same time as particulate air pollution increased 
blood pressure (Hoffmann et al., 2012). Ozone exposure may 
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influence autonomic regulation of the heart rate and has been 
shown to alter circulating inflammatory and fibrinolytic mark-
ers in healthy persons (Chuang et al., 2007; Devlin et al., 2012).
Exposure to dilute diesel exhaust has been consistently asso-
ciated with important effects on vascular function, systemic 
hemodynamics, fibrinolysis, and thrombosis (Cosselman et al., 
2012; Lucking et al., 2008; Mills et al., 2005, 2007; Törnqvist 
et al., 2007). Furthermore, these adverse effects can be abol-
ished by filtration to remove ultrafine particles, suggesting that 
gaseous copollutants are not primarily responsible for the car-
diovascular effects of air pollution (Lucking et al., 2011; Mills 
et al., 2011). The effect of exposure to ozone in isolation on 
microvascular endothelial and fibrinolytic function has not 
been explored.
We hypothesize that short-term exposure to ozone would 
cause acute microvasomotor and fibrinolytic dysfunction in 
healthy men.
MATeRIAls And MeTHOds
Subjects.  Thirty-six healthy, nonsmoking male volunteers of mean age 26 
(range: 21–31) years with normal lung function were recruited (Table 1). All 
subjects reported no ongoing medical conditions, took no regular medication 
(prescribed or over the counter), and were free of the symptoms of respiratory 
tract infection for at least 6 weeks prior to enrollment. All subjects had a nor-
mal baseline 12-lead electrocardiogram (ECG). The local ethical review board 
approved the study, and written informed consent was obtained. The study was 
performed in accordance with Declaration of Helsinki.
Study design. All subjects were exposed to 300 ppb of ozone or filtered 
air in a whole-body exposure chamber of approximately 15 m3 for 75 min on 
two occasions at least two weeks apart in a randomized double-blind crossover 
study (Supplementary data). During exposures, the subjects alternated moder-
ate exercise on a bicycle ergometer to achieve an average minute ventilation of 
20 l/min/m2 body surface area, with rest at 15-min intervals (starting with an 
exercise period).
Venous occlusion forearm plethysmography before and during intra-arterial 
infusion of endothelium-dependent and endothelium-independent vasodilators 
was performed 2–4 h (n = 18) and 6–8 h (n = 18) after all exposures as previ-
ously described (Lucking et al. 2011; Mills et al., 2005, 2007, 2011; Törnqvist 
et al., 2007). A 3-lead continuous ECG was recorded from each subject during 
the exposure and subsequent 24-h period using a Holter monitor (model 90217, 
Spacelabs Healthcare, UK).
Ozone exposure. The exposures were performed in an exposure cham-
ber described in detail elsewhere and in the Supplementary data (Blomberg 
et al., 1999).
Vascular studies. Forearm blood flow (FBF) was determined during 
unilateral brachial artery infusion of endothelium-dependent and -independent 
vasodilators using venous occlusion plethysmography with mercury-in-
silicone elastomer strain gauges, as described previously (Lucking et al. 2011; 
Mills et  al., 2005, 2007, 2011; Törnqvist et  al., 2007). Briefly, the brachial 
artery of one arm was cannulated using a 27-standard wire gauge steel needle, 
and 17 gauge venous cannulae were inserted in large veins in the antecubital 
fossa of both arms. Following a 30-min baseline saline infusion, acetylcholine 
at 5, 10, and 20  µg/min (endothelium-dependent vasodilator that does not 
release tissue plasminogen activator [t-PA]), bradykinin at 100, 300, and 
1000 pmol/min (endothelium-dependent vasodilator that releases t-PA), and 
sodium nitroprusside (SNP) at 2, 4, and 8 µg/min (endothelium-independent 
vasodilator that does not release t-PA) were infused for 6 min at each dose with 
FBF measured for the last 3 min of each infusion. The infusions of the three 
vasodilators were given in a random order and separated by 20-min saline 
infusions. Due to its prolonged action, verapamil at 10, 30, and 100 µg/min 
(endothelium- and nitric oxide–independent vasodilator that does not release 
t-PA) was infused at the end of the study protocol. Blood pressure and heart 
rate were measured during the forearm study using a validated semiautomated 
oscillometric sphygmanometer.
Heart rate variability. ECG recordings were analyzed by an experi-
enced operator, blinded to exposure and the subject characteristics, using the 
Reynolds Medical Pathfinder Digital 700 Series Analysis System (Delmar 
Reynolds) (Supplementary data).
Peripheral blood analyses. Peripheral blood was sampled before and 2 
and 6 h after each exposure for analyses of differential cell counts and fibrino-
lytic and inflammatory markers with samples obtained during the infusion of 
each dose of bradykinin for fibrinolytic markers.
Data analysis and statistics. FBF, t-PA release, and measures of heart 
rate variability (HRV) were analyzed as previously (Lucking et al., 2011; Mills 
et al., 2005, 2007, 2011; Törnqvist et al., 2007) using two-way ANOVA with 
repeated measures or two-tailed Student’s t-tests, where appropriate, using 
GraphPad Prism (GraphPad Software, Version 4 for Macintosh) and SPSS 
(SPSS inc., Chicago, IL, version 15). Statistical significance was defined as 
p < .05.
ResulTs
There were no differences in heart rate, blood pressure, or 
resting FBF 2 or 6 h after exposure to ozone compared with fil-
tered air (Table 2). Systemic inflammatory mediators were not 
affected by exposure to ozone or filtered air (Supplementary 
table S1).
Vascular Studies
Endothelial-dependent and -independent vasodilators caused 
dose-dependent increases in FBF (p  <  .001). There were no 
significant differences in forearm arm blood flow 2–4 h follow-
ing exposure to ozone or filtered air (Fig.  1). At 6–8 h, FBF 
response to acetylcholine and sodium nitroprusside was not 
impaired but rather increased after exposure to ozone com-
pared with filtered air (p = .02 and p = .01, respectively). FBF 
responses to bradykinin and verapamil were similar after both 
exposures (p > .05) (Fig. 2).
TABle 1
Baseline Characteristics of Healthy Volunteers
2–4 h, n = 18 6–8 h, n = 18
Age, years 26 ± 1 26 ± 1
Height, cm 183 ± 3 180 ± 1
Weight, kg 77 ± 3 79 ± 2
BMI, m2/kg 23 ± 1 24 ± 1
FVC, l 5.7 ± 0.2 5.8 ± 0.2
FEV
1
, l 4.3 ± 0.1 4.2 ± 0.1
Note. Values are reported as mean ± SEM; BMI, body mass index; FVC, 
forced vital capacity; FEV
1
, forced expiratory volume in 1 s.
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There were no differences in plasma t-PA or plasminogen 
activator inhibitor-1 antigen concentrations at baseline, 2 h, 
or 6 h following exposure to ozone compared with filtered air 
(Supplementary table S2). The net release of t-PA antigen fol-
lowing bradykinin infusion was unaffected 6–8 h after exposure 
to ozone compared with filtered air (Table 3).
HRV
Subjects did not experience any significant rhythm distur-
bance during the 24-h study period although subjects’ heart rate 
was generally higher through the ozone exposure day (at base-
line and through the study) (Table 4). Exposure to ozone did 
not affect time or frequency domain measures of HRV over the 
24-h period (Supplementary table S3). Measures of HRV aver-
aged over a 5-min interval immediately prior to exposure were 
similar and were not altered at 2 and 6 h following exposure to 
ozone or filtered air (Table 4).
dIsCussIOn
Brief exposure to ozone at a high ambient concentration 
does not impair vascular vasomotor or fibrinolytic function or 
affect HRV in young healthy subjects. Ozone exposure does not 
have a direct and rapid effect on the cardiovascular system, and 
although we cannot exclude an effect of chronic exposure, an 
interaction of ozone and other air pollutants increasing the tox-
icity of these pollutants, or an effect in more susceptible patient 
groups, we suggest that the association between ozone and 
acute cardiovascular morbidity and mortality are due to other 
atmospheric air pollutants rather than exposure to ozone per se.
Although ozone is an irritant gas capable of inducing oxi-
dative stress and inflammation in the airways (Behndig et al., 
2009; Blomberg et al., 1999; Frampton et al., 1999; Stenfors 
et al., 2002), the evidence for cardiovascular effects is less clear. 
Ozone rapidly reacts with low molecular weight antioxidants in 
the lower respiratory tract lining fluid (Behndig et  al., 2009; 
Mudway and Kelly, 2000) and is therefore unlikely to penetrate 
the airway epithelium or directly cause systemic oxidant and 
inflammatory effects. Consistent with this we did not observe 
any change in circulating blood cells, inflammatory cytokines, 
or markers of platelet and endothelial activation. Devlin et al. 
(2012) found a marked fivefold increase in airway neutrophils 
following exposure to ozone at the same concentration consist-
ent with a localized effect in the airways and reported a tran-
sient increase in systemic concentrations of interleukin-8 1 h 
following exposure, consistent with our own findings there 
were no effects on circulating interleukin-6, tumor necrosis fac-
tor, or white blood cells.
Although ozone cannot penetrate the pulmonary epithelium, 
it may activate receptors in the airways that can trigger an 
autonomic reflex to influence regulation of heart rate and 
vascular tone (Lai and Kou, 1998). In murine models, pulmonary 
C-fibers are activated by ozone, thus decreasing heart rate and 
cardiac output while resulting in bronchial vasodilatation (Lee 
and Pisarri, 2001; Taylor-Clark and Undem, 2010). Indeed, 
a change in cardiac autonomic control is one of the central 
mechanistic pathways that have been proposed to explain the 
cardiovascular effects of inhaled air pollutants (Brook et  al., 
2010). Reduced HRV reflects either an increase in sympathetic 
drive and/or a reduction in parasympathetic tone and has been 
associated with increased risk of cardiovascular morbidity 
and mortality (Tsuji et al., 1996). Chuang et al. (2007) found 
a decrease in standard deviation of successive RR intervals, 
root mean square difference of successive RR intervals, low-
frequency power component of HRV, and high-frequency 
power component of HRV (HF) associated with increased 
ambient ozone concentrations averaged over 1–3  days in 
healthy students residing in a heavily polluted urban area in 
Taiwan. Of note, the PM
10
 concentrations during the study 
period were in excess of the World Health Organization’s 
limits of 50 µg/m3, which may be a confounding factor. There 
have been two recent controlled exposure studies to evaluate 
the effect of ozone on HRV (Brook et al., 2009; Devlin et al., 
2012). Devlin et al. (2012) found no effect of exposure to 300 
ppb of ozone on any measure of HRV although they report a 
51% reduction in the 1 h postexposure/pre-exposure HF power 
ratio of uncertain significance. Brook et  al. (2009) similarly 
found no effect of exposure to ozone either in isolation or in 
combination with concentrated ambient particles on HRV. We 
found no effect of exposure to ozone on any measure of HRV 
and suggest that any effect of ozone beyond the airways is not 
mediated by autonomic dysfunction.
It remains possible that ozone may indirectly alter vascular 
function through the generation of secondary oxidized lipo-
proteins in the lung that are able to enter the systemic cir-
culation (Mudway and Kelly, 2000). We assessed vascular 
function in the forearm using a sensitive and repeatable meas-
ure of vasomotor and fibrinolytic function. In contrast to pre-
vious studies evaluating the effects of dilute diesel exhaust on 
TABle 2
Hemodynamic Variables Before Forearm Vascular study, 2 or  
6 h Postexposure to Ozone
Air Ozone p Value
2–4 h, n = 18
 Heart rate, bpm 54 ± 1 54 ± 1 .94
 Systolic blood pressure, mmHg 129 ± 2 130 ± 2 .64
 Diastolic blood pressure, mmHg 67 ± 2 67 ± 2 .35
 Infused FBF, ml/100 ml tissue/min 2.2 ± 0.1 2.0 ± 0.1 .14
 Noninfused FBF, ml/100 ml tissue/min 1.9 ± 0.1 1.8 ± 0.1 .51
6–8 h, n = 18
 Heart rate, bpm 63 ± 2 62 ± 2 .30
 Systolic blood pressure, mmHg 142 ± 3 139 ± 4 .26
 Diastolic blood pressure, mmHg 68 ± 2 67 ± 2 .45
 Infused FBF, ml/100 ml tissue/min 3.2 ± 0.3 3.4 ± 0.4 .55
 Noninfused FBF, ml/100 ml tissue/min 2.6 ± 0.2 2.7 ± 0.2 .86
Note. Values are reported as mean ± SEM. p Values from Student’s paired 
t-tests.
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vascular function (Mills et al., 2005, 2007; Törnqvist et al., 
2007), we found no impairment in vasodilatation to either 
endothelial-dependent or -independent vasodilators follow-
ing exposure to ozone in two separate studies. Nor did ozone 
affect other important aspects of vascular function with the 
stimulated release of t-PA antigen from the vascular endothe-
lium unchanged following exposure. Although it is possible 
that we have missed an important effect of ozone beyond 
8 h (and we acknowledge the findings of Devlin et al., 2012 
who demonstrated small late increases in plasma IL-1 and 
CRP concentrations 24 h after exposure to ozone), this seems 
unlikely given the rapid onset of most oxidation processes. If 
anything, there was an apparent increase in vasodilatation in 
response to acetylcholine and sodium nitroprusside following 
ozone, perhaps suggesting enhanced nitric oxide bioavailabil-
ity in the vasculature. Experimental studies have suggested 
that ip oxygen/ozone can upregulate endothelial nitric oxide 
synthase, reduce nitrotyrosine concentrations, and prevent 
ischaemic injury in an ischaemia-reperfusion model (Di 
Fillipo et al., 2008, 2010), adding plausibility to our obser-
vation. Previous studies have demonstrated that exposure to 
ozone and concentrated ambient particles together caused 
arterial vasoconstriction and increased blood pressure (Brook 
et al., 2002; Urch et al., 2005); however, subsequent studies 
FIg. 1. FBF in subjects 2–4 h after ozone (closed circles) and filtered air (open circles) exposure during unilateral intrabrachial infusion of bradykinin, 
acetylcholine, SNP, and verapamil. Infused arm (solid line); noninfused arm (dotted line).
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have established that these effects are mediated by exposure 
to ambient particles with no effects on arterial tone observed 
following exposure to ozone in isolation (Brook et al., 2009).
Even though epidemiological studies have suggested an asso-
ciation between exposure to ozone and cardiovascular morbidity 
and mortality (Bell et al., 2004, 2007; Ito et al., 2005; Katsouyanni 
et al., 1993; Levy et al., 2005), this relationship is complex and 
difficult to disentangle from the effects of other major air pollut-
ants (Bhaskaran et al., 2009). Indeed, ozone has a complex rela-
tionship with PM air pollution, and in some previous analyses, 
the effect of ozone on cardiovascular mortality is no longer 
apparent following adjustment for PM
2.5
 concentration (Smith 
et al., 2009). There may also be a seasonal bias in some obser-
vational studies as ozone and PM are positively correlated in the 
warm summer months but have a negative association in the cold 
winter months (Langrish et al., 2010). Furthermore, ozone can 
react with other pollutants, and therefore, increased levels may 
reflect changes in the concentrations of other pollutants.
There are some important limitations to this study. Our study 
population included only healthy men, and an effect of ozone on 
FIg. 2. FBF in subjects 6–8 h after ozone (closed circles) and filtered air (open circles) exposure during unilateral intrabrachial infusion of bradykinin, 
acetylcholine, SNP, and verapamil. Infused arm (solid line); noninfused arm (dotted line).
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vascular function in susceptible populations with cardiovascular 
disease cannot be excluded. Furthermore, we cannot exclude 
an effect of chronic exposure to high levels of ozone. We have 
investigated the effects of ozone exposure in isolation and cannot 
exclude the possibility that ozone may have important adverse 
health effects by interacting with and potentially enhancing the 
toxicity of other ambient air pollutants (Bosson et  al., 2008). 
Further research to evaluate the effect of ozone and diesel 
exhaust particles on the cardiovascular system is warranted.
COnClusIOns
This study indicates that short-term exposure to ozone does 
not cause acute impairment in vascular function or alter the 
autonomic regulation of the heart in healthy men. Our findings 
do not support the view that ozone in isolation is an impor-
tant determinant of cardiovascular health. Although we cannot 
exclude an effect of chronic exposure or an interaction between 
ozone and other air pollutants, we suggest that alternative 
pollutants in the ambient mixture may be responsible for the 
adverse cardiovascular health effects attributed to ozone in 
some epidemiologic studies.
suPPleMenTARy dATA
Supplementary data are available online at http://toxsci.
oxfordjournals.org/.
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TABle 3
Plasma t-PA Antigen Concentrations Following Ozone and Filtered Air exposures
6–8 h Air Ozone p Value
Bradykinin, pmol/min 0 100 300 1000 0 100 300 1000
t-PA antigen, ng/ml
 Infused arm 4.5 ± 0.3 6.3 ± 0.6 8.7 ± 0.8 13.7 ± 1.3 5.0 ± 1.6 6.0 ± 1.8 8.1 ± 0.9 11.7 ± 1.3 .16
 Noninfused arm 5.0 ± 0.4 4.5 ± 0.4 4.9 ± 0.4 6.1 ± 0.4 5.2 ± 0.6 4.8 ± 0.4 4.8 ± 0.4 6.1 ± 0.5 .96
Net t-PA release, ng/100 ml 
of tissue/min
−1.4 ± 0.5 12.1 ± 2.9 34.7 ± 5.1 104.1 ± 14.4 −0.2 ± 1.1 8.2 ± 3.0 31.1 ± 5.0 79.6 ± 17.4 .31
Note. Values are reported as mean ± SEM; two-way ANOVA with repeat measures.
TABle 4
HRV at Baseline, 2 h, and 6 h Following exposure to Ozone or Filtered Air
Air Ozone Two-way ANOVA
Baseline 2 h 6 h Baseline 2 h 6 h p Value
Heart rate, bpm 69 ± 2 65 ± 2 65 ± 2 72 ± 2 70 ± 3 66 ± 2 .04
SDNN, ms 91 ± 8 79 ± 5 67 ± 4 90 ± 9 76 ± 6 65 ± 5 .60
RMSSD, ms 54 ± 5 58 ± 5 48 ± 4 52 ± 6 49 ± 5 48 ± 5 .20
PNN50, % 27 ± 4 33 ± 4 26 ± 4 22 ± 4 28 ± 5 27 ± 4 .18
Triangular Ix 19 ± 1 17 ± 1 14 ± 1 17 ± 1 17 ± 1 15 ± 1 .36
HFn, ms 22 ± 2 29 ± 3 28 ± 3 13 ± 2 24 ± 3 31 ± 3 .07
LFn, ms 76 ± 3 68 ± 3 70 ± 3 86 ± 2 72 ± 3 66 ± 3 .10
HF/LF ratio 0.3 ± 0.0 0.5 ± 0.1 0.4 ± 0.1 0.2 ± 0.0 0.4 ± 0.0 0.5 ± 0.1 .86
Note. All variables are presented as mean ± SEM; two-way ANOVA filtered air versus ozone for effect of exposure; SDNN, standard deviation of successive RR 
intervals; RMSSD, root mean square difference of successive RR intervals; HFn, high-frequency power component of HRV expressed in normalized units; LFn, 
low-frequency power component of HRV expressed in normalized units; HF/LF, ratio of high frequency to low frequency components of HRV; PNN50, percentage 
of successive RR intervals that differ by > 50 ms.
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